No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bortezomib / administration & dosage
-
Bortezomib / adverse effects
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Doxorubicin / analogs & derivatives
-
Febrile Neutropenia / chemically induced
-
Female
-
Humans
-
Hydroxyurea / administration & dosage
-
Kaplan-Meier Estimate
-
Leukemia, Myeloid, Acute / drug therapy*
-
Male
-
Middle Aged
-
Neoplastic Cells, Circulating
-
Polyethylene Glycols / administration & dosage
-
Polyethylene Glycols / adverse effects
-
Progression-Free Survival
-
Proteasome Inhibitors / administration & dosage
-
Proteasome Inhibitors / adverse effects
-
Treatment Outcome
Substances
-
Proteasome Inhibitors
-
liposomal doxorubicin
-
Polyethylene Glycols
-
Bortezomib
-
Doxorubicin
-
Hydroxyurea